Last week’s big Retraction Watch news — which got us quoted in the New York Times — was a Nature paper by Amy Wagers and Shane Mayack. The now-retracted paper suggested that the aging of stem cells could be reversed, and Blood has issued a notice of concern about a second paper.
Now comes news about another stem cell finding. The International Journal of Urology has retracted a 2009 paper by Japanese researchers who claimed to have used stem cells derived from fatty tissue to treat urinary incontinence in two men. The men had developed bladder problems after undergoing surgery to remove their cancerous prostates.
According to the editor’s note, the article Continue reading Another stem cell paper retracted, for “breach of established ethical guidelines”
Over the summer, while searching for some studies and evidence for various treatments, my wife, a television writer and producer, noticed something she thought unusual enough to flag for me. The titles of a number of Cochrane Library reviews started with “WITHDRAWN.”
The Cochrane Library is the world’s leading publisher of systematic reviews, which gather all of the high-quality evidence on a given subject and offer a rigorous analysis of whether a given test or treatment works. It’s an invaluable resource. (Shameless plug: Join the Association of Health Care Journalists, where I’m treasurer, and access to the $285-per-year Cochrane subscription is included.)
Retraction Watch was curious about what “WITHDRAWN” meant, since “withdrawal” is often used synonymously with retraction. Cochrane updates its reviews regularly, as new evidence surfaces, of course. But these abstracts didn’t say anything about new reviews.
We asked Jen Beal, who handles media relations for Wiley, the Cochrane Library’s publisher. She responded: Continue reading Progressive: How the Cochrane Library handles updates-in-progress